BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2020
View Archived Issues
Tau keeps gliomas in check
Read More
AVETUX trial shows potential of avelumab and cetuximab with FOLFOX in colorectal cancer
Read More
Janssen Biotech describes new STING agonists
Read More
Cav3.2 blockers patented by Nippon Chemiphar and Kindai University
Read More
HEXAPharmatec discovers new catechol derivatives
Read More
Curis and Aurigene amend their collaboration agreement for CA-170
Read More
Positive update for phase I/IIa study of OpRegen in dry AMD
Read More
Karuna Therapeutics updates research and discovery efforts in CNS
Read More
Novan gives update on the phase III B-SIMPLE program of SB-206
Read More
Phase I data for magrolimab plus avelumab regimen in ovarian cancer
Read More
AVN-576 shows promise in rat models of TBI
Read More
Sino announces IND filing for TDI-01 for fibrosis
Read More
Phase I results for troriluzole plus nivolumab in patients advanced or refractory solid tumors
Read More
Pan-Cancer Project looks closer, sees more
Read More
Genentech describes new NLRP3 inflammasome inhibitors
Read More
Inhibition of HSP90A, a potential strategy to combat NANOG+ immune-refractory tumors
Read More
Low dose eRapa safe and well-tolerated in prostate cancer patients
Read More
Phase III trial of Fintepla in Lennox-Gastaut syndrome meets primary endpoint
Read More
Boehringer Ingelheim studies BI-905681 in phase I for advanced, unresectable or metastatic tumors
Read More
Adial initiates pivotal phase III trial of AD-04 for alcohol use disorder
Read More
Kleo obtains IND clearance to study KP-1237 in combination with NK cells for multiple myeloma
Read More
Betta Pharmaceuticals patents PD-1/PD-L1 interaction inhibitors
Read More
